The Eyes Never Lie: A Rare Cutaneous Manifestation of Hematological Malignancy
DOI:
https://doi.org/10.20344/amp.23335Keywords:
Multiple Myeloma, Necrobiotic XanthogranulomaAbstract
n/a.
Downloads
References
Klingner M, Hansel G, Schönlebe J, Wollina U. Disseminiertes nekrobiotisches Xanthogranulom. Hautarzt. 2016;67:902-6.
Steinhelfer L, Kühnel T, Jägle H, Mayer S, Karrer S, Haubner F, et al. Systemic therapy of necrobiotic xanthogranuloma: a systematic review. Orphanet J Rare Dis. 2022;17:1-9.
Maińska U, Sławińska M, Baran W, Biernat W, Sejda A, Nowicki RJ, et al. Xanthogranuloma necrobioticum in the course of monoclonal gammopathy of undetermined significance and idiopathic neutropenia. Dermatol Rev Pol. 2023;109:453-9.
Szalat R, Pirault J, Fermand JP, Carrié A, Saint-Charles F, Olivier M, et al. Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy. J Intern Med. 2014;276:269-84.
Körber A, Erstdiagnose eines multiplen Myeloms durch nekrobiotisches Xanthogranulom. Dermatologie. 2024;75:727.
Pang L, Rajkumar SV, Kapoor P, Buadi F, Dispenzieri A, Gertz M, et al. Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS). Blood Cancer J. 2021;11:1-8.
Nelson CA, Zhong CS, Hashemi DA, Ashchyan HJ, Brown-Joel Z, Noe MH, et al. A multicenter cross-sectional study and systematic review of necrobiotic xanthogranuloma with proposed diagnostic criteria. JAMA Dermatol. 2020;156:270.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Acta Médica Portuguesa

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

